Language:

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

Biology of blood and marrow transplantation, 2017-10, Vol.23 (10), p.1669-1677

2017 The American Society for Blood and Marrow Transplantation ;Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved. ;ISSN: 1083-8791 ;EISSN: 1523-6536 ;DOI: 10.1016/j.bbmt.2017.06.002 ;PMID: 28602958

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders
Author: Burroughs, Lauri M., MD ; Shimamura, Akiko, MD, PhD ; Talano, Julie-An, MD ; Domm, Jennifer, MD ; Baker, Kelsey, MS ; Delaney, Colleen, MD ; Frangoul, Haydar, MD ; Margolis, David, MD ; Baker, K. Scott, MD, MS ; Geddis, Amy, MD, PhD ; Sandmaier, Brenda M., MD ; Deeg, H. Joachim, MD ; Storb, Rainer, MD ; Woolfrey, Ann E., MD
Subjects: Adolescent ; Antilymphocyte Serum - therapeutic use ; Bone Marrow Diseases - therapy ; Bone marrow failure ; Busulfan - analogs & derivatives ; Busulfan - therapeutic use ; Child ; Child, Preschool ; Diamond Blackfan Anemia ; Disease-Free Survival ; Female ; Graft Survival ; Hematology, Oncology and Palliative Medicine ; Hematopoietic Stem Cell Transplantation - methods ; Humans ; Infant ; Male ; Reduced-toxicity conditioning in nonmalignant diseases ; Shwachman-Diamond Syndrome ; Transplantation Conditioning - methods ; Transplantation, Homologous ; Treatment Outcome ; Vidarabine - analogs & derivatives ; Vidarabine - therapeutic use ; Young Adult
Is Part Of: Biology of blood and marrow transplantation, 2017-10, Vol.23 (10), p.1669-1677
Description: Highlights • Treosulfan-based conditioning has a low toxicity profile • High level donor engraftment in marrow failure disorders • Excellent disease-free survival
Publisher: United States: Elsevier Inc
Language: English
Identifier: ISSN: 1083-8791
EISSN: 1523-6536
DOI: 10.1016/j.bbmt.2017.06.002
PMID: 28602958
Source: MEDLINE
Alma/SFX Local Collection

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

2017 The American Society for Blood and Marrow Transplantation ;Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved. ;ISSN: 1083-8791 ;EISSN: 1523-6536 ;DOI: 10.1016/j.bbmt.2017.06.002 ;PMID: 28602958

Searching Remote Databases, Please Wait